✨ Your Portfolio is fetched and updated from zerodha.

Natco Pharma Ltd.

NATCOPHARM

Market Cap
₹22,125 Cr.
P/E
11.38

Natco Pharma Ltd.

About
Natco Pharma Limited is a vertically integrated pharmaceutical company with a focus on research and development. It specializes in developing, manufacturing, and marketing finished dosage formulations… Read more
Natco Pharma Limited is a vertically integrated pharmaceutical company with a focus on researc… Read more
Low
828
52W Range
High
1639
  • Natco Pharma
  • Pfizer
  • Astrazeneca Pharma I
  • TJI Pharma

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

10 Yes

Positive for this company

3 Neutral

Neutral for this company

4 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share
0.07 %
(as of Jul 22)
Historic
Anti - Diabetes - Market Share
0.74 %
(as of Jul 22)
Historic
Anti-Infectives - Market Share
16.71 %
(as of Nov 21)
Historic
Antineo Plastic - Market Share
0.11 %
(as of Nov 21)
Historic
Blood Related - Market Share
0.56 %
(as of Jul 22)
Historic
Cardiovascular - Market Share
30 %
(as of Mar 19)
Source/Historic
Copaxone - Market Share
Revenue mix

Product Wise Break-Up

Segment Break-Up

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up - Formulation

Location Wise Break-Up

Therapeutic Area Break-Up - Formulation

Operating Profit Break-Up

Asset Break-Up

Operational Metrics

    locked
    Select a Metric
    • US DMF Filings (.)
      Source
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • Domestic Sales Growth - YoY (%)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Brands
    Afinitor
    Aubagio
    Imbruvica
    Kyprolis
    Nexavar
    Pomalyst
    Revlimid
    Sovaldi
    Tarceva
    Tykerb
    Zytiga
    Suppliers
    • Laurus Labs Ltd.
    • Shaily Engineering Plastics Ltd.
    • Take Solutions Ltd.
    FAQs on Natco Pharma Ltd. Business

    Natco Pharma Limited is a vertically integrated pharmaceutical company that focuses on developing, manufacturing, and marketing pharmaceutical products, along with offering contract manufacturing services and crop health sciences division.

    Natco Pharma major competitors are Pfizer, Astrazeneca Pharma I, Alembic Pharma, Eris Lifesciences, Gland Pharma, Wockhardt, Caplin Point Lab.
    Market Cap of Natco Pharma is ₹22,125 Crs.
    While the median market cap of its peers are ₹18,757 Crs.

    Natco Pharma seems to be less financially stable compared to its competitors.
    Altman Z score of Natco Pharma is 15.83 and is ranked 4 out of its 8 competitors.

    View FAQ's On Shareprice
    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary Dec Mar Jun Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Discussions & Analysis
    Natco Pharma Ltd.
    Natco Pharma: Business Model Simplified - JST Investments
    Chasing Optionalities - SOIC
    View the discussion on ValuePickr
    Natco Pharma: Chasing Optionalities - Ankush Agrawal
    Interview with Mr Rajeev Nannapaneni, Vice Chairman & CEO at Natco Pharma - Moneylife
    Business Analysis Of Natco Pharma - Value Educator
    NatcoPharma - Complex generics focused manufacturer - Value Educator
    Natco Pharma: Imminent Growth Cycle (?) - ValuePickr
    A Deep Dive Into Natco Pharma - Numbers and Narratives
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material